Geoff Martha affirmed commitment to profitable growth, reiterating FY25 guidance of mid-single-digit revenue and high-single-digit EPS growth. Larry Biegelsen, Wells Fargo: Asked about cardiac ...

Revenue: $8.3 billion, 4.1% organic growth. Adjusted EPS: $1.39, up 6.9%. Cardiac Ablation Solutions Growth: 22% growth. Leadless Pacing Growth: 24% growth. Neuromodulation Growth: 13% growth.

The medical device maker reported adjusted EPS of $1.39, beating the consensus ... with mid-single digit increases in Cardiac Rhythm & Heart Failure and Structural Heart & Aortic and a low-single ...